|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Machtay M, Paulus R, Moughan J, Komaki R,
Bradley JE, Choy H, Albain K, Movsas B, Sause WT and Curran WJ:
Defining local-regional control and its importance in locally
advanced non-small cell lung carcinoma. J Thorac Oncol. 7:716–722.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Choi EK, Terai K, Ji IM, Kook YH, Park KH,
Oh ET, Griffin RJ, Lim BU, Kim JS, Lee DS, et al: Upregulation of
NAD(P)H:quinone oxidoreductase by radiation potentiates the effect
of bioreductive beta-lapachone on cancer cells. Neoplasia.
9:634–642. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jeong SY, Park SJ, Yoon SM, Jung J, Woo
HN, Yi SL, Song SY, Park HJ, Kim C, Lee JS, et al: Systemic
delivery and preclinical evaluation of Au nanoparticle containing
beta-lapachone for radiosensitization. J Control Release.
139:239–245. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang J, Xia S and Zhu Z: Synergistic
effect of phenformin in non-small cell lung cancer (NSCLC) ionizing
radiation treatment. Cell Biochem Biophys. 71:513–518. 2015.
View Article : Google Scholar
|
|
6
|
Zou YM, Hu GY, Zhao XQ, Lu T, Zhu F, Yu SY
and Xiong H: Hypoxia-induced autophagy contributes to
radioresistance via c-Jun-mediated beclin1 expression in lung
cancer cells. J Huazhong Univ Sci Technolog Med Sci. 34:761–767.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dang L, Wen F, Yang Y, Liu D, Wu K, Qi Y,
Li X, Zhao J, Zhu D, Zhang C, et al: Proteasome inhibitor MG132
inhibits the proliferation and promotes the cisplatin-induced
apoptosis of human esophageal squamous cell carcinoma cells. Int J
Mol Med. 33:1083–1088. 2014.PubMed/NCBI
|
|
8
|
Ma J, Yu L, Tian J, Mu Y, Lv Z, Zou J, Li
J, Wang H and Xu W: MG132 reverse the malignant characteristics of
hypopharyngeal cancer. Mol Med Rep. 9:2587–2591. 2014.PubMed/NCBI
|
|
9
|
Ortiz-Lazareno PC, Bravo-Cuellar A,
Lerma-Díaz JM, Jave-Suárez LF, Aguilar-Lemarroy A,
Domínguez-Rodríguez JR, González-Ramella O, De Célis R,
Gómez-Lomelí P and Hernández-Flores G: Sensitization of U937
leukemia cells to doxorubicin by the MG132 proteasome inhibitor
induces an increase in apoptosis by suppressing NF-kappa B and
mitochondrial membrane potential loss. Cancer Cell Int. 14:132014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zeng RX, Zhang YB, Fan Y and Wu GL:
p62/SQSTM1 is involved in caspase-8 associated cell death induced
by proteasome inhibitor MG132 in U87MG cells. Cell Biol Int.
38:1221–1226. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Deeb D, Gao X, Liu YB, Pindolia K and
Gautam SC: Pristimerin, a quinonemethide triterpenoid, induces
apoptosis in pancreatic cancer cells through the inhibition of
pro-survival Akt/NF-κB/mTOR signaling proteins and anti-apoptotic
Bcl-2. Int J Oncol. 44:1707–1715. 2014.PubMed/NCBI
|
|
12
|
Pajonk F, van Ophoven A, Weissenberger C
and McBride WH: The proteasome inhibitor MG-132 sensitizes PC-3
prostate cancer cells to ionizing radiation by a DNA-PK-independent
mechanism. BMC Cancer. 5:762005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Warren G, Grimes K, Xu Y, Kudrimoti M and
St Clair W: Selectively enhanced radiation sensitivity in prostate
cancer cells associated with proteasome inhibition. Oncol Rep.
15:1287–1291. 2006.PubMed/NCBI
|
|
14
|
Grimes KR, Daosukho C, Zhao Y, Meigooni A
and St Clair W: Proteasome inhibition improves fractionated
radiation treatment against non-small cell lung cancer: An
antioxidant connection. Int J Oncol. 27:1047–1052. 2005.PubMed/NCBI
|
|
15
|
Liu J, Shen W, Tang Y, Zhou J, Li M, Zhu
W, Yang H, Wu J, Zhang S and Cao J: Proteasome inhibitor MG132
enhances the antigrowth and antimetastasis effects of radiation in
human nonsmall cell lung cancer cells. Tumour Biol. 35:7531–7539.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Letouzey M, Penther D, Roche-Lestienne C,
Nelken B, Devoldère C, vannier JP and Schneider P: Detection of
dicentric chromosome (9;20) in paediatric B-cell acute
lymphoblastic leukaemia: Prognostic significance. Ann Hematol.
34:187–193. 2015. View Article : Google Scholar
|
|
17
|
Ahn KS and Aggarwal BB: Transcription
factor NF-kappaB: A sensor for smoke and stress signals. Ann NY
Acad Sci. 1056:218–233. 2005. View Article : Google Scholar
|
|
18
|
Xue J, Dong JH, Huang GD, Qu XF, Wu G and
Dong XR: NF-κB signaling modulates radiation induced microglial
activation. Oncol Rep. 31:2555–2560. 2014.PubMed/NCBI
|
|
19
|
Faria SL: Role of radiotherapy in
metastatic non-small cell lung cancer. Front Oncol. 4:2292014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Okawara G, Mackay JA, Evans WK and Ung YC;
Lung Cancer Disease Site Group of Cancer Care Ontario's Program in
evidence-based Care: Management of unresected stage III non-small
cell lung cancer: A systematic review. J Thorac Oncol. 1:377–393.
2006. View Article : Google Scholar
|
|
21
|
Cao KI, Lebas N, Gerber S, Levy C, Le
Scodan R, Bourgier C, Pierga JY, Gobillion A, Savignoni A and
Kirova YM: Phase II randomized study of whole-brain radiation
therapy with or without concurrent temozolomide for brain
metastases from breast cancer. Ann Oncol. 26:89–94. 2015.
View Article : Google Scholar
|
|
22
|
Dai Y, Li C, Xie Y, Liu X, Zhang J, Zhou
J, Pan X and Yang S: Interventions for dysphagia in oesophageal
cancer. Cochrane Database Syst Rev. 10:CD0050482014.PubMed/NCBI
|
|
23
|
Paliwal R, Kumar-Patidar A, Walke R,
Hirapara P, Jain S and Raj-Bardia M: Palliative hypo-fractionated
radiotherapy in locally advanced head and neck cancer with fixed
neck nodes. Iran J Cancer Prev. 5:178–182. 2012.PubMed/NCBI
|
|
24
|
Scott KA, Dalgleish AG and Liu WM: The
combination of cannabidiol and Δ9-tetrahydrocannabinol enhances the
anticancer effects of radiation in an orthotopic murine glioma
model. Mol Cancer Ther. 13:2955–2967. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bola BM, Chadwick AL, Michopoulos F,
Blount KG, Telfer BA, Williams KJ, Smith PD, Critchlow SE and
Stratford IJ: Inhibition of monocarboxylate transporter-1 (MCT1) by
AZD3965 enhances radiosensitivity by reducing lactate transport.
Mol Cancer Ther. 13:2805–2816. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pujol M, Barquinero JF, Puig P, Puig R,
Caballín MR and Barrios L: A new model of biodosimetry to integrate
low and high doses. PLoS One. 9:e1141372014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bender MA, Awa AA, Brooks AL, Evans HJ,
Groer PG, Littlefield LG, Pereira C, Preston RJ and Wachholz BW:
Current status of cytogenetic procedures to detect and quantify
previous exposures to radiation. Mutat Res. 196:103–159. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mackinnon RN and Campbell LJ: The role of
dicentric chromosome formation and secondary centromere deletion in
the evolution of myeloid malignancy. Genet Res Int.
2011:6436282011.PubMed/NCBI
|
|
29
|
Yamamoto K, Matsuoka H, Funakoshi Y,
Yakushijin K, Okamura A, Itoh T and Minami H: A novel dicentric
chromosome, dic(9;9)(p12;q34), leading to trisomy 9 in follicular
lymphoma without t(14;18). Leuk Res. 35:e100–e103. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gascoigne KE and Cheeseman IM: Induced
dicentric chromosome formation promotes genomic rearrangements and
tumorigenesis. Chromosome Res. 21:407–418. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sun Y, St Clair DK, Fang F, Warren GW,
Rangnekar VM, Crooks PA and St Clair WH: The radiosensitization
effect of parthenolide in prostate cancer cells is mediated by
nuclear factor-kappaB inhibition and enhanced by the presence of
PTEN. Mol Cancer Ther. 6:2477–2486. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Aravindan S, Natarajan M, Herman TS,
Awasthi V and Aravindan N: Molecular basis of 'hypoxic' breast
cancer cell radio-sensitization: Phytochemicals converge on
radiation induced Rel signaling. Radiat Oncol. 8:462013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kozakai N, Kikuchi E, Hasegawa M, Suzuki
E, Ide H, Miyajima A, Horiguchi Y, Nakashima J, umezawa K,
Shigematsu N, et al: enhancement of radiosensitivity by a unique
novel NF-κB inhibitor, DHMEQ, in prostate cancer. Br J Cancer.
107:652–657. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Starenki DV, Namba H, Saenko VA, Ohtsuru
A, Maeda S, Umezawa K and Yamashita S: Induction of thyroid cancer
cell apoptosis by a novel nuclear factor kappaB inhibitor,
dehydroxymethyl epoxyquinomicin. Clin Cancer Res. 10:6821–6829.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tang G, Minemoto Y, Dibling B, Purcell NH,
Li Z, Karin M and Lin A: Inhibition of JNK activation through
NF-kappaB target genes. Nature. 414:313–317. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen X, Shen B, Xia L, Khaletzkiy A, Chu
D, Wong JY and Li JJ: Activation of nuclear factor kappaB in
radioresistance of TP53-inactive human keratinocytes. Cancer Res.
62:1213–1221. 2002.PubMed/NCBI
|
|
37
|
Ji Y, Zheng M, Ye S, Chen J and Chen Y:
PTEN and Ki67 expression is associated with clinicopathologic
features of non-small cell lung cancer. J Biomed Res. 28:462–467.
2014.PubMed/NCBI
|
|
38
|
Antonarakis ES, Keizman D, Zhang Z, Gurel
B, Lotan TL, Hicks JL, Fedor HL, Carducci MA, De Marzo AM and
Eisenberger MA: An immunohistochemical signature comprising PTEN,
MYC, and Ki67 predicts progression in prostate cancer patients
receiving adjuvant docetaxel after prostatectomy. Cancer.
118:6063–6071. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
He X, Chen Z, Fu T, Jin X, Yu T, Liang Y,
Zhao X and Huang L: Ki-67 is a valuable prognostic predictor of
lymphoma but its utility varies in lymphoma subtypes: Evidence from
a systematic meta-analysis. BMC Cancer. 14:1532014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yerushalmi R, Woods R, Ravdin PM, Hayes MM
and Gelmon KA: Ki67 in breast cancer: Prognostic and predictive
potential. Lancet Oncol. 11:174–183. 2010. View Article : Google Scholar : PubMed/NCBI
|
